This trial will test whether adding a PSMA PET scan to the standard of care MRI scan before surgery helps doctors better understand the cancer and leads to better patient outcomes.
1 Primary · 9 Secondary · Reporting Duration: 18 months
Active Control
Experimental Treatment
288 Total Participants · 2 Treatment Groups
Primary Treatment: PSMA-PET and SOC MRI · No Placebo Group · Phase 2 & 3
Age Any Age · Male Participants · 4 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: